Sign In
Buy COWN
$38.99
+0 (+0%)
At Close: May 26, 2023
Merck to Participate in the TD Cowen 46th Annual Health Care Conference
06:45am, Tuesday, 24'th Feb 2026
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the TD Cowen 46th Annual Health Care Conference.
Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference
04:16pm, Monday, 23'rd Feb 2026
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference.
Puma Biotechnology to Present at TD Cowen's 46th Annual Health Care Conference
04:15pm, Monday, 23'rd Feb 2026
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology CEO & President Alan Auerbach will provide a corporate overview at the TD Cowen Health Care Conference on March 2 at 2:30 pm ET.
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
04:15pm, Monday, 23'rd Feb 2026
VALENCIA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
04:05pm, Monday, 23'rd Feb 2026
EMERYVILLE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference
10:00am, Monday, 23'rd Feb 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the TD Cowen
Caris Life Sciences to Participate in the TD Cowen 46th Annual Health Care Conference
08:30am, Monday, 23'rd Feb 2026
IRVING, Texas, Feb. 23, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced tha
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
08:00am, Monday, 23'rd Feb 2026
WEST CHESTER, Pa., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin disease
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
08:00am, Monday, 23'rd Feb 2026
BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will be presenting an
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference
08:00am, Monday, 23'rd Feb 2026
IRVINE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating
United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference
07:00am, Monday, 23'rd Feb 2026
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that Michael Benkowitz, President and Chief Operating Officer, will p
Apellis Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference
07:00am, Monday, 23'rd Feb 2026
WALTHAM, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will participate in a webcast fireside chat at the TD Cowen 46th Annual
argenx to Present at TD Cowen 46th Annual Healthcare Conference
01:00am, Monday, 23'rd Feb 2026
February 23, 2026 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, tod
Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference
08:00am, Friday, 20'th Feb 2026
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of card
Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
07:00am, Friday, 20'th Feb 2026
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™)
